Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies

Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies

Cancer and cardiovascular diseases are the leading causes of death and morbidity worldwide. Strikingly, cardiovascular disorders are more common and more severe in cancer patients than in the general population, increasing incidence rates. In this context, it is vital to consider the anticancer effi...

Full description

Bibliographic Details
Main Authors: Gabriel Silva Marques Borges, Eduardo Burgarelli Lages, Pierre Sicard, Lucas Antônio Miranda Ferreira, Sylvain Richard
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
anticancer drugs
cardiotoxicity
nanoformulations
non-invasive imaging
echography
photoacoustic
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.690533/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.690533/full

Similar Items